Camel Milk Based Pharmaceutical Composition

Abstract

The present invention relates to a novel pharmaceutical composition with milk of immunized camelid, particularly Camelus dromedaries as the main component (i.e. active ingredient) and a method for the treatment or prevention of skin or mucus membrane infections, particularly Acne vulgaris. The present invention also discloses a process of preparing said composition.

1 . A pharmaceutical composition comprising treated immunized Camelid milk in a pharmaceutically acceptable vehicle for the treatment or prevention of skin or mucus membrane diseases. 
     
     
         2 . The pharmaceutical composition of  claim 1 , wherein said Camelid is from the genus  Camelus, Llama , or  Vicuna.    
     
     
         3 . The pharmaceutical composition of  claim 2 , wherein said camelid is  Camelus dromedarius.    
     
     
         4 . The pharmaceutical composition of  claim 1 , wherein said camelid is immunized with skin or mucus membrane pathogen. 
     
     
         5 . The pharmaceutical composition of  claim 4 , wherein said pathogen is  Propionobacterium acne, Staphylococcus aureus, Streptococcus mutans, Pseudomonas aeroginosa, Haemophilus influenza, Neisseria  OJ spp.  Candida  spps or  Chlamydia trachomatus.    
     
     
         6 . The pharmaceutical composition of  claim 5 , wherein said pathogen is intact or any a fraction treated with heat, formalin or cell lysate. 
     
     
         7 . The pharmaceutical composition of  claim 1 , wherein said immunized camel milk is treated at a temperature of 0° C. for 1-2 hours and centrifuged at 15000 rpm for the removal of lipids. 
     
     
         8 . The pharmaceutical composition of  claim 1 , wherein said immunized camelid milk is treated enzymatically or chemically to reduce protein content. 
     
     
         9 . The pharmaceutical composition of  claim 8 , wherein said enzyme is rennin, and said chemical is acetic acid. 
     
     
         10 . The pharmaceutical composition of  claim 1 , wherein said composition can be in the form of cream, ointment, gel, skin wash, lotion, soap, shampoo, mouth wash, vaginal wash, eye wash, tooth paste, or spray. 
     
     
         11 . A process of preparing the pharmaceutical composition of  claim 1 , comprising;
 Immunizing a female camelid with a vaccine of  Propionobacterium acne, Staphylococcus aureus, Streptococcus mutans, Pseudomonas aeroginosa, Haemophilus influenza, Neissenriae  spp.  Cancfida  spps or  Chlamydia trachomatus;      Obtaining milk from the camelid;   Treating the milk at a temperature of 0 nc for 1-2 hours and centrifuging at 15000 rpm to remove lipids;   Treating the milk with rennin or acetic acid to reduce protein content;   Pasteurizing the milk at a temperature ranging from 65° C. to 72° C. for 15 mmutes; and   Preparing the milk in a pharmaceutically acceptable vehicle.   
     
     
         12 . The process of  claim 11 , wherein said camelid is from the genus  Camelus, Llama , or  Vicuna.    
     
     
         13 . The process of  claim 12 , wherein said camelid is  Camelus dromedarius.    
     
     
         14 . The process of  claim 11 , wherein said composition can be in the form of cream, ointment, gel, skin wash, lotion, soap, shampoo, mouth wash, vaginal wash, eye wash, tooth paste or spray. 
     
     
         15 . A method for the treatment or prevention of skin or mucus membrane infections, comprising applying to an infected area of the human body an effective amount of the composition of  claim 1 . 
     
     
         16 . The method of  claim 15 , wherein said infections are caused by  Propionobacterium acne, Staphylococcus aureus, Streptococcus mutans, Pseudomonas aeroginosa, Haemophilus influenza, Neisseriae  spp.  Candida  spps or  Chlamydia trachomatus.